International Network of VENous Thromboembolism Clinical Research Networks

TILE

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome

Sponsors:

Sunnybrook Health Sciences Centre

Toronto, Canada   

Status:

  • Seeking sites and collaborators

Design

Pilot RCT comparing 3-weeks of tinzaparin then DOAC vs DOAC alone for prevention of PTS in high-risk symptomatic DVT patients (Iliac vein or common femoral vein)

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Canada, France

Lead Investigators

Dr. Jean-Philippe Galanaud, Md, PhD

Sunnybrook Health Sciences Centre

Toronto, Ontario

Jean-Philippe.Galanaud@sunnybrook.ca
Dr. Susan Kahn

Dr. Susan Kahn, MD, MSc

susan.kahn@mcgill.ca

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.